Literature DB >> 16243227

Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features.

Farzana P Darbari1, Joseph J Melvin, Joseph H Piatt, Terry A Adirim, Sanjeev V Kothare.   

Abstract

Intrathecal baclofen therapy is increasingly used to alleviate medically intractable spasticity in children with cerebral palsy, spinal cord injuries, and generalized dystonia. Complications like overdose or withdrawal can occur and could be the result of pump malfunction (device-related) or refilling and programming mistakes (human errors). This report describes a case, with emphasis on electroencephalographic changes, of a 12-year old male on long-term intrathecal baclofen therapy who had sequential occurrence of both acute inadvertent baclofen overdose followed by withdrawal symptoms. During baclofen intoxication, electroencephalography documented periodic generalized epileptiform discharges, occasionally followed by intermittent electro-decremental responses on a background of diffuse delta slowing (1-2 Hz). During withdrawal, mild generalized slowing during wakefulness was observed along with the appearance of high-amplitude, sharply contoured delta activity resembling frontal intermittent rhythmic delta activity in sleep. To our knowledge, this temporal profile of electroencephalographic features during baclofen intoxication followed by withdrawal has not been described before in pediatric patients. It is important for treating physicians to recognize the evolution of this electroencephalographic pattern in order to avoid misinterpretation of diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243227     DOI: 10.1016/j.pediatrneurol.2005.05.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  [Intrathecal baclofen therapy. Overdose during replacement of a medication pump].

Authors:  K Kramer; M Weber; A Koulousakis; H Lier; H Krep
Journal:  Anaesthesist       Date:  2009-09       Impact factor: 1.041

2.  Problem-Solving in Patients with Targeted Drug Delivery Systems.

Authors:  Rez Farid
Journal:  Mo Med       Date:  2017 Jan-Feb

3.  Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan; H Daniel Adams; Zhiyuan Ma
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

4.  Accidental intoxication with 60 mg intrathecal baclofen: survived.

Authors:  Benjamin Berger; Barbara Vienenkoetter; Mirjam Korporal; Andrea Rocco; Hans-Michael Meinck; Thorsten Steiner
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

5.  Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation.

Authors:  Julie Vienne; Bernhard Bettler; Paul Franken; Mehdi Tafti
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

Review 6.  Therapeutic interventions for tone abnormalities in cerebral palsy.

Authors:  Ann H Tilton
Journal:  NeuroRx       Date:  2006-04

7.  Baclofen facilitates sleep, neuroplasticity, and recovery after stroke in rats.

Authors:  Aleksandra Hodor; Svitlana Palchykova; Francesca Baracchi; Daniela Noain; Claudio L Bassetti
Journal:  Ann Clin Transl Neurol       Date:  2014-10-14       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.